Loading...

APL Asston Pharmaceuticals Ltd Changes in management or control Announcement

sstn

PL

Asston Pharmaceuticals Ltd

(APL)

2025 Announcement

Regulatory compliance exemp...

Regulatory Compliance

Record date for EGM

Appointment of CFO and Dire...

Appointments of CFO and Dir...

Appointments and Directors

Insider trading window

Appointment of Statutory Au...

Appointment of Auditors

Meeting Cancellation

Trading Window Closure

Auditor Resignation

Resignation of Auditor

Authorised Capital Increase

Geographic Expansion

Regulatory Compliance

Car loan facility

Car loan facility

Board Meeting Intimation

Manufacturing capacity expa...

Geographic Expansion

Capacity expansion

Board Meeting Intimation

Compliance Certificate

New Director Appointed

Board Meeting Updates

New Appointment

Board Meeting Outcome

CFO Resignation

Company Secretary Resignation

Newspaper Publication

New Purchase Order

Purchase Order Received

External Links:

Data:

Mr. Deven Manohar Patil has resigned from his position as Chief Financial Officer (CFO) of Asston Pharmaceuticals Ltd effective October 13, 2025, to pursue other career opportunities.

AI Assistant

Asston Pharmaceuticals Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.